International Biotechnology Trust plc (IBT) Ordinary 25p Shares

International Biotechnology Trust plc is a United Kingdom-based investment trust company. The Company’s investment objective is to achieve long-term capital growth by investing in biotechnology and other life sciences companies. It seeks to achieve its objective by investing in a diversified portfolio of companies which may be quoted or unquoted and whose shares are considered to have good growth prospects, with suitably experienced management and potential upside through the development and/or commercialization of a product, device or enabling technology. Its investments may also be made in related sectors, such as medical devices and healthcare services. It may invest through equities, index-linked securities and debt securities, cash deposits, money market instruments and foreign currency exchange transactions. Schroder Investment Management Limited is the investment manager of the Company. Schroder Unit Trusts Limited is the alternative investment fund manager of the Company.

The Company’s investment objective is to achieve long-term capital growth by investing in biotechnology and other life sciences companies. The Company will seek to achieve its objective by investing in a diversified portfolio of companies which may be quoted or unquoted and whose shares are considered to have good growth prospects, with suitably experienced management and strong potential upside through the development and/or commercialisation of a product, device or enabling technology.

• Ongoing charge1.35%
• Annual management charge -
• Performance feeYes

Management fee payable monthly at the rate of 0.7% p.a. of the NAV. The performance fee on the unquoted pool is 20% of net realised gain performance fee on the quoted pool is 10% of relative outperformance above the sterling-adjusted NBI plus a 0.5% hurdle. Investment Management Agreement is terminable by either party on 12 months written notice.